203 related articles for article (PubMed ID: 30952702)
21. Carbon Ion Radiotherapy Acts as the Optimal Treatment Strategy for Unresectable Liver Cancer During the Coronavirus Disease 2019 Crisis.
Li Z; Li Q; Wang X; Li S; Chen W; Jin X; Liu X; Dai Z; Liu X; Zheng X; Li P; Zhang H; Zhang Q; Luo H; Liu R
Front Public Health; 2021; 9():767617. PubMed ID: 34957022
[TBL] [Abstract][Full Text] [Related]
22. Carbon Ion Radiotherapy in the Treatment of Hepatocellular Carcinoma.
Byun HK; Kim C; Seong J
Clin Mol Hepatol; 2023 Oct; 29(4):945-957. PubMed ID: 37583055
[TBL] [Abstract][Full Text] [Related]
23. A systematic review of the role of carbon ion radiation therapy in recurrent rectal cancer.
Venkatesulu BP; Giridhar P; Malouf TD; Trifletti DM; Krishnan S
Acta Oncol; 2020 Oct; 59(10):1218-1223. PubMed ID: 32476538
[TBL] [Abstract][Full Text] [Related]
24. [Present status of carbon ion radiotherapy for malignant tumors].
Sugahara S; Kamada T
Gan To Kagaku Ryoho; 2009 Nov; 36(11):1795-800. PubMed ID: 19920380
[TBL] [Abstract][Full Text] [Related]
25. Paediatric brain tumours: A review of radiotherapy, state of the art and challenges for the future regarding protontherapy and carbontherapy.
Laprie A; Hu Y; Alapetite C; Carrie C; Habrand JL; Bolle S; Bondiau PY; Ducassou A; Huchet A; Bertozzi AI; Perel Y; Moyal É; Balosso J;
Cancer Radiother; 2015 Dec; 19(8):775-89. PubMed ID: 26548600
[TBL] [Abstract][Full Text] [Related]
26. A multi-institutional analysis of prospective studies of carbon ion radiotherapy for prostate cancer: A report from the Japan Carbon ion Radiation Oncology Study Group (J-CROS).
Nomiya T; Tsuji H; Kawamura H; Ohno T; Toyama S; Shioyama Y; Nakayama Y; Nemoto K; Tsujii H; Kamada T
Radiother Oncol; 2016 Nov; 121(2):288-293. PubMed ID: 27836119
[TBL] [Abstract][Full Text] [Related]
27. Feasibility of carbon ion radiotherapy for locally advanced sinonasal adenocarcinoma.
Koto M; Hasegawa A; Takagi R; Sasahara G; Ikawa H; Mizoe JE; Jingu K; Tsujii H; Kamada T; Okamoto Y;
Radiother Oncol; 2014 Oct; 113(1):60-5. PubMed ID: 25287484
[TBL] [Abstract][Full Text] [Related]
28. A meta-analysis comparing efficacy and safety between proton beam therapy versus carbon ion radiotherapy.
Jang JY; Kim K; Chen MF; Akimoto T; Wang MLC; Kim MJ; Kim K; Lee TH; Yoo GS; Park HC
Cancer Med; 2024 Feb; 13(3):e7023. PubMed ID: 38396380
[TBL] [Abstract][Full Text] [Related]
29. The Role of Carbon Ion Therapy in the Changing Oncology Landscape-A Narrative Review of the Literature and the Decade of Carbon Ion Experience at the Italian National Center for Oncological Hadrontherapy.
Orlandi E; Barcellini A; Vischioni B; Fiore MR; Vitolo V; Iannalfi A; Bonora M; Chalaszczyk A; Ingargiola R; Riva G; Ronchi S; Valvo F; Fossati P; Ciocca M; Mirandola A; Molinelli S; Pella A; Baroni G; Pullia MG; Facoetti A; Orecchia R; Licitra L; Vago G; Rossi S
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894434
[TBL] [Abstract][Full Text] [Related]
30. Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation.
Hummel S; Simpson EL; Hemingway P; Stevenson MD; Rees A
Health Technol Assess; 2010 Oct; 14(47):1-108, iii-iv. PubMed ID: 21029717
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for brain injury after carbon ion radiotherapy for skull base tumors.
Koto M; Hasegawa A; Takagi R; Fujikawa A; Morikawa T; Kishimoto R; Jingu K; Tsujii H; Kamada T
Radiother Oncol; 2014 Apr; 111(1):25-9. PubMed ID: 24332023
[TBL] [Abstract][Full Text] [Related]
32. Carbon Ion Radiotherapy for sacral chordoma: a systematic review of the literature.
Evangelisti G; Sartini F; Bandiera S; Barbanti Brodano G; Griffoni C; Girolami M; Pipola V; Gasbarrini A
J Biol Regul Homeost Agents; 2020; 34(4 Suppl. 3):353-361. Congress of the Italian Orthopaedic Research Society. PubMed ID: 33261300
[TBL] [Abstract][Full Text] [Related]
33. Updated long-term outcomes after carbon-ion radiotherapy for primary renal cell carcinoma.
Kasuya G; Tsuji H; Nomiya T; Makishima H; Haruyama Y; Kobashi G; Ebner DK; Hayashi K; Omatsu T; Kishimoto R; Yasuda S; Igarashi T; Oya M; Akakura K; Suzuki H; Ichikawa T; Shimazaki J; Kamada T;
Cancer Sci; 2018 Sep; 109(9):2873-2880. PubMed ID: 29981249
[TBL] [Abstract][Full Text] [Related]
34. The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model.
Crathorne L; Huxley N; Haasova M; Snowsill T; Jones-Hughes T; Hoyle M; Briscoe S; Coelho H; Long L; Medina-Lara A; Mujica-Mota R; Napier M; Hyde C
Health Technol Assess; 2016 Feb; 20(13):1-588, v-vi. PubMed ID: 26907163
[TBL] [Abstract][Full Text] [Related]
35. Monte Carlo study of out-of-field exposure in carbon-ion radiotherapy with a passive beam: Organ doses in prostate cancer treatment.
Yonai S; Matsufuji N; Akahane K
Phys Med; 2018 Jul; 51():48-55. PubMed ID: 29699921
[TBL] [Abstract][Full Text] [Related]
36. Proton Beam Therapy and Carbon Ion Radiotherapy for Hepatocellular Carcinoma.
Apisarnthanarax S; Bowen SR; Combs SE
Semin Radiat Oncol; 2018 Oct; 28(4):309-320. PubMed ID: 30309641
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
